A new study from FAIR Health, in collaboration with the West Health Institute and Marty Makary, MD, MPH, from Johns Hopkins University School of Medicine, shows the relationship between preexisting comorbidities of COVID-19 and mortality in privately insured patients. The study has been released as a white paper entitled Risk Factors for COVID-19 Mortality among Privately Insured Patients: A Claims Data Analysis.
Across all age groups, the top three comorbidity risk factors for death from COVID-19 were, in order from highest to lowest risk, developmental disorders (e.g., developmental disorders of speech and language, developmental disorders of scholastic skills, central auditory processing disorders), lung cancer, and intellectual disabilities and related conditions (e.g., Down syndrome and other chromosomal anomalies; mild, moderate, severe and profound intellectual disabilities; congenital malformations, such as certain disorders that cause microcephaly). As detailed in the white paper, these findings are supported by recent scientific literature.
The findings were based on an analysis of data from the nation’s largest private healthcare claims database, the FAIR Health National Private Insurance Claims (FH NPIC®) repository. Evaluating all patients in FH NPIC’s longitudinal dataset, FAIR Health identified 467,773 patients diagnosed with COVID-19 from April 1, 2020, through August 31, 2020. Relationships were examined between the outcome of mortality (dependent variable) and the following independent variables: age, gender and preexisting comorbidities.
- Risk Factors for COVID-19 Mortality among Privately Insured Patients: A Claims Data Analysis. A FAIR Health White Paper in Collaboration with the West Health Institute and Marty Makary, MD, MPH, from Johns Hopkins University School of Medicine, November 11, 2020